The Center of Regenerative Medicine (CRM) at Washington University in St. Louis proposes an
interdisciplinary postdoctoral training program in regenerative medicine. Breakthroughs in various
bioengineering and stem cell technologies over the past decade have provided unprecedented opportunities
for the development of new regenerative technologies, yet there is a lack of individuals who have received
formal interdisciplinary training. This program will be used to develop an integrated training structure that
provides a unique, multidisciplinary experience for postdoctoral fellows in one of four research thrusts: 1)
Development in the context of regeneration; 2) Cell fate engineering; 3) Biomaterials for cell and tissue
engineering; and 4) Molecules, genes, and cells as regenerative therapeutics. The program involves over 40
faculty from 20 separate departments and divisions across Washington University. Trainees will be guided by
a mentoring committee, and an integral aspect of this training program will be the creation of a formal training
plan for each individual trainee, based on a self-assessment of skills and career goals (the Individual
Development Plan). Interdisciplinary training will be supplemented by workshops in complementary areas,
including statistical analysis, writing, and mandatory training in research ethics. We will also take advantage of
several long-standing and successful initiatives at Washington University to enhance the recruitment of
underrepresented minorities as part of this post-doctoral training program. Our primary goal is to develop
highly trained individuals who can produce impactful interdisciplinary research in regenerative medicine.
Public Health Relevance Statement
There is currently a lack of engineers and scientists who have formal interdisciplinary training focused on
regenerative medicine. This program will be used to develop an integrated training structure that provides a
unique, multidisciplinary experience for postdoctoral fellows, allowing them to more efficiently translate
scientific discoveries, with the ultimate goal of improving patient outcomes.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-August-2020
Project End Date
31-July-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$229,249
Direct Costs
$256,932
Indirect Costs
$18,755
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$229,249
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5T32EB028092-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32EB028092-05
Patents
No Patents information available for 5T32EB028092-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32EB028092-05
Clinical Studies
No Clinical Studies information available for 5T32EB028092-05
News and More
Related News Releases
No news release information available for 5T32EB028092-05
History
No Historical information available for 5T32EB028092-05
Similar Projects
No Similar Projects information available for 5T32EB028092-05